Viral mixed infection complicated by acute hepatitis and allergic toxic dermatitis (clinical case)-Reference-Cited by-同舟云学术

Viral mixed infection complicated by acute hepatitis and allergic toxic dermatitis (clinical case)

Published:2022-10-19 Issue:5 Volume:16 Page:71-74
ISSN:2310-158X
Container-title:Modern Rheumatology Journal
language:
Short-container-title:Sovremennaâ revmatologiâ

Author:

Aronova E. S.¹^ORCID,Belov B. S.¹^ORCID,Gridneva G. I.¹^ORCID

Affiliation:

1. V.A. Nasonova Research Institute of Rheumatology

Abstract

Epstein-Barr virus (EBV) belongs to the family of herpesviruses (herpes type 4) and is one of the most common and highly contagious. During the pandemic of a new coronavirus disease, it was found that in patients previously infected with EBV, COVID-19 can cause its reactivation, which is often manifested by the clinic of acute hepatitis. The article presents a clinical case of the development of acute hepatitis in a patient with mixed infection with EBV and SARS-CoV-2 in combination with allergic toxic reaction while taking sulfasalazine prescribed for spondyloarthritis. A feature of this case was the development of severe hepatitis of mixed genesis with a favorable outcome. The importance of adherence to drug monitoring rules for newly prescribed drugs for COVID-19 was emphasized. In severe cases of the disease, the possibility of mixed infection should be taken into account.

Publisher

IMA Press, LLC

Subject

Pharmacology (medical),Immunology,Immunology and Allergy,Rheumatology

Reference23 articles.

1. Nadeem A, Suresh K, Awais H, Waseem S. Epstein-Barr Virus Coinfection in COVID-19. J Investig Med High Impact Case Rep. Jan-Dec 2021;9:23247096211040626. doi: 10.1177/23247096211040626.

2. Brunet-Possenti F, Steff M, Marinho E, et al. Syndrome de Stevens-Johnson au cours d'une primo-infection par le virus d'Epstein-Barr. Ann Dermatol Venereol. 2013 Feb;140(2):112-5. doi: 10.1016/j.annder.2012.10.590. Epub 2012 Dec 10.

3. Federal'nye klinicheskie rekomendatsii po vedeniyu bol'nykh sindromom Stivensa– Dzhonsona / toksicheskim epidermal'nym nekrolizom [Federal clinical guidelines for the management of patients with Stevens—Johnson syndrome / toxic epidermal necrolysis]. Moscow: Rossiiskoe obshchestvo dermatovenerologov i kosmetologov; 2015.

4. Kartashova MG. Stephens-Johnson syndrome. Rossiiskii zhurnal kozhnykh i venericheskikh boleznei. 2012;(6):13-7. (In Russ.).

5. Frantz R, Huang S, Are A, Motaparthi K. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management. Medicina (Kaunas). 2021 Aug 28; 57(9):895. doi: 10.3390/medicina57090895.